Clinical Trials Browser

Phase 2/3 × OTHER × pertuzumab × Clear all

Urinary Bladder Neoplasms, Gallbladder Neoplasms, Lung Neoplasms, Neoplasms, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Salivary Gland Neoplasms, Skin Neoplasms, Colorectal Neoplasms, Hematologic Neoplasms

NCT05722886 2025-11-24

DETERMINE

Phase 2/3 Recruiting

825 enrolled

LymphoidOther hematologic neoplasm

Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Hematologic Neoplasms

NCT05426486 2024-10-30

A Study of ARX788 Combined With Pyrotinib Maleate Versus TCBHP (Trastuzumab Plus Pertuzumab With Docetaxel and Carboplatin) as Neoadjuvant Treatment in HER2-positive Breast Cancer Patients

Phase 2/3 Active not recruiting

136 enrolled

Breast

HER2-positive Breast Cancer

NCT02568839 2020-08-13

PREDIX HER2

Phase 2/3 Active not recruiting

202 enrolled

Breast

Breast Neoplasms

NCT02581462 2020-08-11

PETRARCA

Phase 2/3 Completed

81 enrolled

Gastrointestinal

Stomach Neoplasms